[HTML][HTML] Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2
PJ Hesketh, K Chansky, AJ Wozniak, FR Hirsch… - Journal of Thoracic …, 2008 - Elsevier
Purpose This phase II study (S0341) evaluated the efficacy and tolerability of single-agent
erlotinib in unselected chemotherapy-naive patients with advanced non-small cell lung …
erlotinib in unselected chemotherapy-naive patients with advanced non-small cell lung …
Southwest Oncology Group Phase II Trial (S0341) of Erlotinib (OSI-774) in Patients with Advanced Non-small Cell Lung Cancer and a Performance Status of 2
PJ Hesketh, K Chansky, AJ Wozniak, FR Hirsch… - Journal of Thoracic …, 2008 - jto.org
Purpose This phase II study (S0341) evaluated the efficacy and tolerability of single-agent
erlotinib in unselected chemotherapy-naive patients with advanced non-small cell lung …
erlotinib in unselected chemotherapy-naive patients with advanced non-small cell lung …
[引用][C] Southwest Oncology Group Phase II Trial (S0341) of Erlotinib (OSI-774) in Patients with Advanced Non-small Cell Lung Cancer and a Performance Status of 2
PJ Hesketh, K Chansky, AJ Wozniak… - Journal of Thoracic …, 2008 - cir.nii.ac.jp
Southwest Oncology Group Phase II Trial (S0341) of Erlotinib (OSI-774) in Patients with
Advanced Non-small Cell Lung Cancer and a Performance Status of 2 | CiNii Research CiNii …
Advanced Non-small Cell Lung Cancer and a Performance Status of 2 | CiNii Research CiNii …
Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2.
PJ Hesketh, K Chansky, AJ Wozniak… - Journal of Thoracic …, 2008 - europepmc.org
Purpose This phase II study (S0341) evaluated the efficacy and tolerability of single-agent
erlotinib in unselected chemotherapy-naive patients with advanced non-small cell lung …
erlotinib in unselected chemotherapy-naive patients with advanced non-small cell lung …
[HTML][HTML] SOUTHWEST ONCOLOGY GROUP PHASE II TRIAL (S0341) OF ERLOTINIB (OSI-774) IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER …
PJ Hesketh, K Chansky, AJ Wozniak… - Journal of thoracic …, 2008 - ncbi.nlm.nih.gov
Purpose This phase II study (S0341) evaluated the efficacy and tolerability of single-agent
erlotinib in unselected chemotherapy-naïve patients with advanced non-small cell lung …
erlotinib in unselected chemotherapy-naïve patients with advanced non-small cell lung …
Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2
PJ Hesketh, K Chansky, AJ Wozniak… - Journal of thoracic …, 2008 - pubmed.ncbi.nlm.nih.gov
Purpose This phase II study (S0341) evaluated the efficacy and tolerability of single-agent
erlotinib in unselected chemotherapy-naive patients with advanced non-small cell lung …
erlotinib in unselected chemotherapy-naive patients with advanced non-small cell lung …